Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
about
The gastric HK-ATPase: structure, function, and inhibitionThe gastric H,K ATPase as a drug target: past, present, and futurePharmacology of proton pump inhibitorsPrevalence of gastrointestinal diseases in two British national birth cohortsTreatment of Helicobacter pylori infection: Current and future insightsEuropean College of Equine Internal Medicine Consensus Statement--Equine Gastric Ulcer Syndrome in Adult HorsesPotassium Channelopathies and Gastrointestinal UlcerationMolecular mechanisms in therapy of acid-related diseasesEffects of SCH 32651 on resting and stimulated acid secretion in guinea-pig isolated fundic mucosaSynergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult WormsBenzimidazole covalent probes and the gastric H(+)/K(+)-ATPase as a model system for protein labeling in a copper-free settingRecent advances in the treatment of duodenal ulcer disease. A surgical perspective.Personal review: is profound acid inhibition safe?Review article: the control of gastric acid and Helicobacter pylori eradication.Omeprazole as adjunct to enzyme replacement in severe pancreatic insufficiency.Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolismIdentification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism.Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19Influence of acid secretory status on absorption of omeprazole from enteric coated granules.Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine.Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects.A study of the interaction of omeprazole and warfarin in anticoagulated patientsEffect of substituted benzimidazoles on acid secretion in isolated and enriched guinea pig parietal cells.Basal, sham feed and pentagastrin stimulated gastric acid, pepsin and electrolytes after omeprazole 20 mg and 40 mg daily.Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer.Action of gastrin in guinea pig oxyntic cells. Studies using quantitative cytochemistry.The effect of omeprazole on gastric emptying in patients with duodenal ulcer diseaseIntravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits.Repositioning proton pump inhibitors as anticancer drugs by targeting the thioesterase domain of human fatty acid synthaseOxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitroLong-term safety of proton pump inhibitors: risks of gastric neoplasia and infections.Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole.Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.Evolution of extreme stomach pH in bilateria inferred from gastric alkalization mechanisms in basal deuterostomes.Rebound hypersecretion after inhibition of gastric acid secretion.Site selective syntheses of [(3)H]omeprazole using hydrogen isotope exchange chemistry.Ouabain-insensitive K-adenosine triphosphatase in distal nephron segments of the rabbit.Designing Irreversible Inhibitors--Worth the Effort?The sulphoxide moiety of substituted benzimidazoles is essential for inhibition of parietal cell K+/H+-ATPaseInhibition of partially purified K+/H+-ATPase from guinea-pig isolated and enriched parietal cells by substituted benzimidazoles
P2860
Q24612375-1C3BA43F-BD01-4C04-B84D-AE868C424FD6Q24631084-6F1479B3-190F-4C43-9171-7889A936950DQ24634771-88DF098A-2B4F-40E0-99F7-3FC76423A705Q24669663-2E8B707A-8FA1-4F88-9507-9D671EE9F9C0Q26769707-DA9A48F0-423A-4D4E-8076-D9725DFDEA6AQ26784263-200D660D-8FAC-452E-8F51-6267DB991493Q28072892-81561431-7F8D-446C-8BB1-87399DF4C636Q28252872-EE7DF555-E93D-4B5A-B0C2-807D351CBEADQ28365689-F4BAE789-249A-48EA-9552-63CBF47F6E05Q28548401-A2D5F1D5-0C18-4FA5-A908-B3E43382AD78Q28833519-532085F4-54A8-4C45-87BC-98CCB9DEAA40Q33614823-6953318F-057A-4CE8-A015-6DE2BF8BF6C8Q33815745-A6B9B89E-65DE-49D5-9123-BE393D81A4F0Q34078518-FEF7B7B7-A653-49F6-83FA-63FA1D05AF5FQ34289394-51E8AD96-A55B-490E-BE85-9DA85775D74FQ34345774-9ECFA5C6-3B00-4052-AE4A-2BD214C79A22Q34346434-90459AA9-A738-4B36-BA8C-31386758E05CQ34347232-DCC416C8-D02B-4683-8A78-0BD589468CF7Q34358008-87307D29-EA76-4292-B4BB-16797D9E7DB8Q34378195-AC0187A6-097C-4D38-B83B-C56A4785D50AQ34398436-B25A7D12-C705-496E-956A-11C7D570E46DQ34403343-8C4ACBD8-0FF7-400B-BE34-093185A40A37Q34495996-3EEC08C8-E802-4418-BD7B-5C3EF52ED201Q34527647-BE911E39-E095-4823-98E9-8EC4E2ECB744Q34532837-BB025C83-EBE9-49A2-94F7-A3AAC4CB1DBAQ34611402-E49E25EB-21C9-4C76-B0B1-CB7A7CB9FEEBQ34621589-5FB61E2F-C4C1-4DF3-8886-98F3CE4DCFA9Q34735634-A7575C94-491E-4D4B-AFD5-7F76C2641240Q35013508-9B5455A5-4F00-427B-8053-C7BAB15C3F77Q35125188-B6BCF9A3-9DFF-446B-9790-4604C83F8B8BQ35194532-B49A4F02-1695-43F7-8CC4-78CB293BC597Q35354635-104867E6-6028-4BB7-AA8F-BE13A3ED74E5Q35605579-6E091997-2BB1-4FE1-BB97-F26D47660041Q35692581-B5791208-A80C-4379-B5D5-8B226361E70FQ35763890-6FF9F399-D01E-4860-BC7A-0AD77265F969Q35779080-04FCBDC7-3BED-4858-8AE4-E8A1B3E5B025Q35811612-3957B2E8-957F-4F5F-8A68-94C8AEC37C28Q35848315-0C71168F-5A27-4D9D-8F51-C19D123B2947Q35886851-5FCC23BD-C13B-49C2-8C69-2DA9D73482F4Q36003829-C7E673CF-7F8D-4699-83C4-39B3695F807E
P2860
Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
description
1981 nî lūn-bûn
@nan
1981 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի մարտին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
@ast
Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
@en
Substituted benzimidazoles inhibit gastric acid secretion by blocking
@nl
type
label
Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
@ast
Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
@en
Substituted benzimidazoles inhibit gastric acid secretion by blocking
@nl
prefLabel
Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
@ast
Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
@en
Substituted benzimidazoles inhibit gastric acid secretion by blocking
@nl
P2093
P356
P1433
P1476
Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
@en
P2093
Berglindh T
Fellenius E
Sjöstrand SE
Wallmark B
P2888
P304
P356
10.1038/290159A0
P407
P577
1981-03-01T00:00:00Z
P5875
P6179
1048250516